Teva Must Pay Baxter’s $144M Hepatitis Damages: Judge

Law360, New York (September 20, 2011, 5:45 PM EDT) -- A Delaware judge on Thursday upheld an arbitration panel's ruling that an indemnity agreement obligates Teva Pharmaceuticals USA Inc. to pay Baxter Healthcare Corp.'s damages — at least $144 million — in sweeping litigation blaming the drugmakers' marketing of anesthetic Propofol for a hepatitis C outbreak.

In May 2010, the first of many Propofol-related suits to go to trial resulted in $500 million punitive damages against the two companies — including $144 million against Baxter, according to the complaint. That lawsuit involved the headmaster of a...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.